Varian Medical Systems Inc. (VAR)

117.03
2.30 2.00
NYSE : Health Technology
Prev Close 114.70
Open 114.70
Day Low/High 113.33 / 117.05
52 Wk Low/High 101.42 / 130.29
Volume 354.51K
Avg Volume 725.60K
Exchange NYSE
Shares Outstanding 91.55M
Market Cap 10.80B
EPS 1.60
P/E Ratio 49.13
Div & Yield N.A. (N.A)

Latest News

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

Varian Reports Results For Fourth Quarter And Full Fiscal Year 2018

PALO ALTO, Calif., Oct.

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

Varian Unveils New Bravos Afterloader System For Brachytherapy Treatments

PALO ALTO, Calif., Oct.

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Varian Forms FlashForward Consortium To Study Ultra-high Dose Rate Cancer Treatments With Protons

Consortium focused on preclinical research, clinical implementation and advocacy

Varian Introduces New ProBeam 360° Proton Therapy System

Varian Introduces New ProBeam 360° Proton Therapy System

PALO ALTO, Calif., Oct.

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

PALO ALTO, Calif., Oct.

Varian Signs Educational Partnerships With Reliance Group In India

Varian Signs Educational Partnerships With Reliance Group In India

Varian Advanced Radiotherapy Clinical School Established at Group's Flagship Hospital in Mumbai

Varian Appoints New Division Presidents

Varian Appoints New Division Presidents

Veteran Varian Leaders Kolleen T. Kennedy and Chris Toth Step into New Roles

Varian Shares Vision Of A World Without Fear Of Cancer

Varian Shares Vision Of A World Without Fear Of Cancer

Company publishes "The Future of Cancer Care: Moving from Promise to Reality"

Dr. Jeff Balser Named To Varian Board Of Directors

Dr. Jeff Balser Named To Varian Board Of Directors

PALO ALTO, Calif., Sept.

Epic Sciences Announces Completion Of $52 Million Series E Financing

Epic Sciences Announces Completion Of $52 Million Series E Financing

Proceeds will be used to advance liquid biopsy tests to predict drug response in cancer patients and to integrate company's No Cell Left Behind platform with electronic medical records and big data analytics

Varian Signs Partnership Agreement With Mediheal To Support Cancer Care In Kenya

Varian Signs Partnership Agreement With Mediheal To Support Cancer Care In Kenya

PALO ALTO, Calif. and NAIROBI, Kenya, Sept.

Varian To Present At Baird Global Healthcare Conference

Varian To Present At Baird Global Healthcare Conference

PALO ALTO, Calif., Aug.

Varian CEO Dow Wilson Joins USISPF Board Of Directors

Varian CEO Dow Wilson Joins USISPF Board Of Directors

PALO ALTO, Calif., Aug.

Varian Announces Acquisition Of HumediQ Global GmbH

Varian Announces Acquisition Of HumediQ Global GmbH

Acquisition expands Varian's motion-management portfolio and presence in Germany

Varian Reports Results For Third Quarter Of Fiscal Year 2018

Varian Reports Results For Third Quarter Of Fiscal Year 2018

Third Quarter 2018 Summary

Varian Showcases Advanced Cancer Care Solutions At AAPM 2018

Varian Showcases Advanced Cancer Care Solutions At AAPM 2018

PALO ALTO, Calif., July 24, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing its advanced cancer care solutions including a new version of Eclipse ™ treatment planning software with support for Halcyon ™ 2.

Varian Installs ProBeam Cyclotron At UCLH Proton Beam Therapy Center

Varian Installs ProBeam Cyclotron At UCLH Proton Beam Therapy Center

PALO ALTO, Calif., June 19, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of a Varian ProBeam ® cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England.

Varian Provides Update On Proposed Sirtex Acquisition

Varian Provides Update On Proposed Sirtex Acquisition

PALO ALTO, Calif., June 14, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received notification from Sirtex Medical Limited (Sirtex) on June 14, 2018 that its board has determined that the proposal from CDH Investments and China Grand...

Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date

Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date

PALO ALTO, Calif., June 11, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018.

Varian To Demonstrate Advanced Brachytherapy Solutions At ABS 2018

Varian To Demonstrate Advanced Brachytherapy Solutions At ABS 2018

PALO ALTO, Calif., June 5, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be demonstrating its comprehensive portfolio of advanced brachytherapy solutions, June 7-9 in San Francisco, CA at the American Brachytherapy Society Annual Meeting...

Varian Medical Systems Becomes #156 Most Shorted S&P 500 Component, Replacing Xylem

The most recent short interest data has been released for the 05/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B+ (Buy)